These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33478421)

  • 21. The right of access to healthcare: an analysis of how legal and institutional frameworks constrain or facilitate access to healthcare for residents in border areas in the East African Community.
    Ssengooba F; Babirye S; Tuhebwe D; Ssennyonjo A; Ssendagire S; Rutaroh A; Mutesa L; Nangami M
    Int J Equity Health; 2022 Nov; 21(1):168. PubMed ID: 36435794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
    Ncube BM; Dube A; Ward K
    Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda.
    Shabani JBB; Kayitare E; Nyirimigabo E; Habyalimana V; Murindahabi MM; Ntirenganya L; Irasabwa C; Rutungwa E; Munyangaju JE; Hahirwa I
    J Pharm Policy Pract; 2022 Nov; 15(1):90. PubMed ID: 36434730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-Term Training, a Useful Approach for Sustainable Pharmacovigilance Knowledge Development in Tanzania, Kenya, Ethiopia and Rwanda.
    van Puijenbroek E; Barry A; Khaemba C; Ntirenganya L; Gebreyesus TD; Fimbo A; Minzi O; Makonnen E; Oluka M; Guantai A; Aklillu E
    Drug Saf; 2024 Dec; 47(12):1193-1202. PubMed ID: 39162987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
    [No Abstract]   [Full Text] [Related]  

  • 27. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.
    Narsai K; Masekela FB; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Health Serv Res; 2024 Jan; 24(1):111. PubMed ID: 38245720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
    Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
    Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities.
    Thambavita D; Galappatthy P; Jayakody RL
    J Pharm Policy Pract; 2018; 11():14. PubMed ID: 29951208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis.
    Tiemersma EW; Ali I; Alemu A; Avong YK; Duga A; Elagbaje C; Isah A; Kay A; Mmbaga BT; Mmari E; Mwamwitwa K; Nhlabatsi S; Sintayehu K; Arefayne A; Teferi M; Cobelens F; Härmark L
    BMC Health Serv Res; 2021 Oct; 21(1):1062. PubMed ID: 34625085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
    Ncube BM; Dube A; Ward K
    Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Institutionalization of African traditional medicine in health care systems in Africa.
    Kofi-Tsekpo M
    Afr J Health Sci; 2004; 11(1-2):i-ii. PubMed ID: 17298111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
    Roth L; Bempong D; Babigumira JB; Banoo S; Cooke E; Jeffreys D; Kasonde L; Leufkens HGM; Lim JCW; Lumpkin M; Mahlangu G; Peeling RW; Rees H; Ndomondo-Sigonda M; Stergachis A; Ward M; Nwokike J
    Global Health; 2018 Nov; 14(1):102. PubMed ID: 30382856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
    McAuslane N; Bujar M; Sithole T; Ngum N; Owusu-Asante M; Walker S
    Pharmaceut Med; 2023 May; 37(3):251-260. PubMed ID: 37074548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections.
    Geyer ARC; Sousa VD; Silveira D
    PLoS One; 2018; 13(8):e0202084. PubMed ID: 30089162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
    Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
    BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.
    Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
    Front Pharmacol; 2022; 13():1031289. PubMed ID: 36408267
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.